ES2133380T3 - Composiciones farmaceuticas que contienen glicosidos de antraciclina unidos a derivados polimeros, y su procedimiento de preparacion. - Google Patents

Composiciones farmaceuticas que contienen glicosidos de antraciclina unidos a derivados polimeros, y su procedimiento de preparacion.

Info

Publication number
ES2133380T3
ES2133380T3 ES93902124T ES93902124T ES2133380T3 ES 2133380 T3 ES2133380 T3 ES 2133380T3 ES 93902124 T ES93902124 T ES 93902124T ES 93902124 T ES93902124 T ES 93902124T ES 2133380 T3 ES2133380 T3 ES 2133380T3
Authority
ES
Spain
Prior art keywords
anthracicline
pharmaceutical compositions
compositions containing
preparation procedure
polymer derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93902124T
Other languages
English (en)
Inventor
Marco Adami
Roberto Magrini
Paolo Maranghi
Antonino Suarato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Application granted granted Critical
Publication of ES2133380T3 publication Critical patent/ES2133380T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PRESENTA UNA COMPOSICION LIOFILIZADA QUE COMPRENDE (A) UN CONJUGADO QUE COMPRENDE UN COPOLIMERO BASADO EN METACRILAMIDO DE N-ALQUIL Y UN GLICOSIDO DE ANTRACICLINA ENLAZADO A TRAVES DE SEPARADOR PEPTIDO AL COPOLIMERO Y (B) UN AGENTE COSOLUBILIZANTE, LA COMPOSICION PUEDE CONTENER OPCIONALMENTE (C) UN MATERIAL DE RELLENO. TAMBIEN OPCIONALMENTE, UNA MOLECULA PUEDE ESTAR UNIDA AL COPOLIMERO DEL CONJUGADO POR MEDIO DE UN SEPARADOR PEPTIDO. ASIMISMO SE PRESENTA UNA SOLUCION INYECTABLE DE CONJUGADO QUE SE OBTIENE MEDIANTE LA RECONSTITUCION DE LA COMPOSICION LIOFILIZADA.
ES93902124T 1992-01-07 1992-12-21 Composiciones farmaceuticas que contienen glicosidos de antraciclina unidos a derivados polimeros, y su procedimiento de preparacion. Expired - Lifetime ES2133380T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929200247A GB9200247D0 (en) 1992-01-07 1992-01-07 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation

Publications (1)

Publication Number Publication Date
ES2133380T3 true ES2133380T3 (es) 1999-09-16

Family

ID=10708214

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93902124T Expired - Lifetime ES2133380T3 (es) 1992-01-07 1992-12-21 Composiciones farmaceuticas que contienen glicosidos de antraciclina unidos a derivados polimeros, y su procedimiento de preparacion.

Country Status (22)

Country Link
US (1) US6245358B1 (es)
EP (1) EP0574571B1 (es)
JP (1) JPH06505755A (es)
KR (1) KR100290222B1 (es)
AT (1) ATE179618T1 (es)
AU (1) AU666513B2 (es)
CA (1) CA2105466A1 (es)
DE (1) DE69229109T2 (es)
DK (1) DK0574571T3 (es)
ES (1) ES2133380T3 (es)
FI (1) FI933853L (es)
GB (1) GB9200247D0 (es)
GR (1) GR3030633T3 (es)
HU (2) HU217806B (es)
IL (1) IL104256A (es)
MX (1) MX9207605A (es)
NZ (1) NZ246577A (es)
RU (1) RU2118171C1 (es)
TW (1) TW218847B (es)
UA (1) UA32522C2 (es)
WO (1) WO1993013804A1 (es)
ZA (1) ZA9210049B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320781D0 (en) * 1993-10-08 1993-12-01 Erba Carlo Spa Polymer-bound camptothecin derivatives
JP3107726B2 (ja) 1994-05-13 2000-11-13 株式会社クラレ 水膨潤性高分子ゲル
US5965118A (en) * 1997-04-18 1999-10-12 Access Pharmaceuticals, Inc. Polymer-platinum compounds
WO1998047496A2 (en) * 1997-04-18 1998-10-29 Access Pharmaceuticals, Inc. Polymer-platinum compounds
US7314956B2 (en) 2001-08-08 2008-01-01 Vaxim, Inc. Multifunctional carrier for the delivery of a pharmacological agent or genetic material into a cell
WO2003017938A2 (en) * 2001-08-22 2003-03-06 Watson Pharmaceuticals, Inc. Conjugates targeted to target receptors
US20030125268A1 (en) * 2002-08-28 2003-07-03 Rybak Mary Ellen Margaret Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
CN1703198A (zh) * 2002-10-25 2005-11-30 辉瑞产品公司 呈混悬剂形式的芳基杂环活性物质的贮库制剂
KR20050100617A (ko) * 2003-01-14 2005-10-19 테바 파마슈티컬 인더스트리즈 리미티드 전신 홍반 루푸스 치료용 펩티드의 비 경구 제형
RU2283646C2 (ru) * 2004-04-27 2006-09-20 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Раствор простакор для инъекций
BRPI0605832A2 (pt) * 2005-05-11 2009-05-26 Sicor Inc glicosìdeos de antraciclina liofilizados estáveis
RU2317102C1 (ru) * 2006-05-31 2008-02-20 Автономная некоммерческая организация "Институт молекулярной диагностики" (АНО "ИнМоДи") Пептид, являющийся аналогом фрагмента альфа-фетопротеина, конъюгат пептида с доксорубицином и фармацевтическая композиция на его основе для лечения онкологических заболеваний
US20100160442A1 (en) * 2006-07-18 2010-06-24 Ossovskaya Valeria S Formulations for cancer treatment
EP2121139B1 (en) * 2007-01-16 2012-10-10 BiPar Sciences, Inc. Formulations for cancer treatment
RU2488393C2 (ru) * 2007-11-12 2013-07-27 Новартис Аг Жидкие композиции, включающие валсартан
WO2009118754A2 (en) * 2008-03-28 2009-10-01 Astron Research Limited A process for preparing a stable lyophilized composition
CA2723315A1 (en) * 2008-04-30 2009-11-05 Ben-Gurion University Of The Negev Research And Development Authority Vascular delivery systems
KR102239752B1 (ko) * 2019-12-11 2021-04-13 한국과학기술연구원 종양 특이적 약물복합체와 항pd-l1 항체를 유효성분으로 하는 암 예방 또는 치료를 위한 병용 투여용 약학 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS173846B1 (es) * 1974-04-23 1977-03-31
CS173849B1 (es) * 1974-04-25 1977-03-31
US4460560A (en) * 1982-06-18 1984-07-17 University Of Southern California Drug delivery by polymeric carriers
FR2561916B1 (fr) * 1984-03-30 1987-12-11 Lafon Labor Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
FR2583983B1 (fr) * 1985-06-07 1988-05-27 Centre Nat Rech Scient Nouvelles prodrogues macromoleculaires hydrosolubles, leur preparation et leur utilisation comme medicaments notamment antitumoraux et antiparasitaires
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
US4968742A (en) * 1987-11-09 1990-11-06 Miles Inc. Preparation of ligand-polymer conjugate having a controlled number of introduced ligands
US5135736A (en) * 1988-08-15 1992-08-04 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
US5094848A (en) * 1989-06-30 1992-03-10 Neorx Corporation Cleavable diphosphate and amidated diphosphate linkers
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs

Also Published As

Publication number Publication date
GB9200247D0 (en) 1992-02-26
DE69229109D1 (de) 1999-06-10
UA32522C2 (uk) 2001-02-15
FI933853A7 (fi) 1993-09-03
DE69229109T2 (de) 1999-08-26
US6245358B1 (en) 2001-06-12
DK0574571T3 (da) 1999-11-01
CA2105466A1 (en) 1993-07-08
HUT74578A (en) 1997-01-28
WO1993013804A1 (en) 1993-07-22
HU211636A9 (en) 1995-12-28
FI933853A0 (fi) 1993-09-03
EP0574571B1 (en) 1999-05-06
ATE179618T1 (de) 1999-05-15
FI933853L (fi) 1993-09-03
GR3030633T3 (en) 1999-10-29
JPH06505755A (ja) 1994-06-30
EP0574571A1 (en) 1993-12-22
IL104256A0 (en) 1993-05-13
ZA9210049B (en) 1993-10-06
AU666513B2 (en) 1996-02-15
KR100290222B1 (ko) 2001-09-17
HU9302517D0 (en) 1993-12-28
IL104256A (en) 1997-02-18
TW218847B (es) 1994-01-11
NZ246577A (en) 1996-03-26
MX9207605A (es) 1993-08-01
RU2118171C1 (ru) 1998-08-27
HU217806B (hu) 2000-04-28
AU3346893A (en) 1993-08-03

Similar Documents

Publication Publication Date Title
ES2133380T3 (es) Composiciones farmaceuticas que contienen glicosidos de antraciclina unidos a derivados polimeros, y su procedimiento de preparacion.
MX9203072A (es) Asialoglucoproteina-agente conjugado medicinal.
DE69310518D1 (de) Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält
HUP9802394A2 (hu) Szulfatált oligoszacharidok és ezeket hatóanyagként tartalmazó gyógyszerkészítmények
JPS5436359A (en) Preparation of polyolefin film
KR880000089A (ko) 서방형 약제 조성물
ES2075129T3 (es) Preparacion de gel que contiene estrogeno.
ES2094359T3 (es) Formulaciones farmaceuticas de proteinas osteogenicas.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
NZ501950A (en) Medicinal compositions for application to mucosa
ES8800605A1 (es) Procedimiento para preparar una composicion coloeada de utilidad en cirugia ocular.
CA2157323A1 (en) Gepirone dosage form
DE59407457D1 (de) Blockierung der anlagerung von keimen an menschliche zellen
RU93055778A (ru) Фармацевтические композиции, содержащие антрациклиновые гликозиды, связанные с полимерным производным, и способ их получения
FR2734481B1 (fr) Pseudo-emulsions stabilisees et leur procede de preparation
HUT57203A (en) Process for substituted benzimidazol and paharmaceutical composition containing them
IT8823121A0 (it) Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali
IT8867891A0 (it) Derivati terziobutilati di benzilidene canfora procedimento per la loro preparazione,loro impiego come agenti anti ossidanti e composizioni cosmetiche e farmaceutiche che li contengono
KR930021206A (ko) 시타라빈 옥포스페이트 경질 캡슐제
ES2150305T3 (es) Composicion anhidra a base de lactulosa.
KR970032876A (ko) 간장질환 치료용 의약 조성물
Yokoyama et al. Effect of dental luting cements from the viewpoint of cell recovery (in vitro)
IT1213568B (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1228462B (it) Derivati del 1 arilsolfonil pirrolidin 2 tione oppure del 1 arilsolfonil piperidin 2 tione, loro procedimento di preparazione e loro impiego come medicinali.
IT1186775B (it) Derivati nuobosidici aventi proprieta' antierpetiche,composizioni farmaceutiche che li contengono e procedimento per la preparazione degli ingredienti attivi

Legal Events

Date Code Title Description
FA2A Application withdrawn

Effective date: 19940628

FG2A Definitive protection

Ref document number: 574571

Country of ref document: ES